| domain | biopharmadive.com |
| summary | Here’s a summary of the website content:
Due to a brain tumor development in a study, a Hurler syndrome therapy was temporarily halted during early testing, and a Hunter syndrome treatment’s FDA decision was delayed. Increased licensing deals for early drug candidates, particularly cell and gene therapies (which have faced funding challenges in the U.S.), are expected to continue throughout the year. |
| title | Biotech and Pharma Industry News | BioPharma Dive |
| description | BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more. |
| keywords | biotech, drug, newsletter, dive, images, gene, weekly, therapy, obesity, pharma, industry, china, policy, trials, deals, news, editing |
| upstreams |
techtarget.com |
| downstreams |
|
| nslookup | A 104.18.42.32, A 172.64.145.224 |
| created | 2025-03-27 |
| updated | 2026-02-02 |
| summarized | 2026-02-03 |
|
|